Enzymes
Enzymes(酶)
Enzymes are very efficient and specific catalyst proteins which react with 1 or few types of substrates in biochemical reactions and are responsible for bringing about almost all of the chemical reactions in living organisms. Enzymes speed up reactions by providing an alternative reaction pathway of lower activation energy. Without enzymes, reactions take place at a rate far too slow for the pace of metabolism which means that they speed up the chemical reactions in living things.
There are 2 types of enzymes, ones that help join specific molecules together to form new molecules & others that help break specific molecules apart into separate molecules. Enzymes play many important roles ouside the cell as well. One of the best examples of this is the digestive system. For instance, it is enzymes in your digestive system that break food down in your digestive system break food down into small molecules that can be absorbed by the body. Some enzymes in your digestive system break down starch, some proteins and others break down fats. The enzymes used to digest our food are extra-cellular since they are located outside our cells & enzymes inside our cells are intra-cellular enzymes. Enzymes are used in ALL chemical reactions in living things; this includes respiration, photosynthesis, movement growth, getting rid of toxic chemicals in the liver and so on. Enzymes are proteins that must have the correct structure to be active. They are very easily affected by heat, pH and heavy metal ions.
Ribonucleoprotein enzyme catalytic activity is located in the protein part but for some the catalytic activity is in the RNA part. A catalyst is any substance which makes a chemical reaction go faster, without itself being changed. A catalyst can be used over and over again in a chemical reaction and does not get used up.
Enzymes lower the amount of activation energy needed by binding to the reactants of the reaction they catalyze, thus speed up the reaction and can process millions of molecules per second. Enzymes are typically large proteins with high molecular weight that permit reactions to go at conditions that the body can tolerate.
Enzyme nomenclature is based on what the enzyme reacts with & how it reacts along with the ending ase.
Enzymes must get over the activation energy hurdle.
Enzymes change how a reaction will proceed which reduces the activation energy and makes it faster. The more we increase the enzyme concentration the faster the reaction rate for non-catalyzed reactions. Enzymes that are catalyzed reactions also increase reaction rate at higher level of concentration but up to a certain point called Vmax which means that the enzyme has reached its maximum point. The reaction is limited by both the concentrations of the enzyme and substrate. Enzymes as catalysts take part in reactions which provide an alternative reaction pathway. Enzymes do not undergo permanent changes and remain unchanged at the end of the reaction. They only change the rate of reaction, not the position of the equilibrium.Enzymes as catalysts are highly selective by only catalysing specific reactions due to the shapes of the enzyme’s molecule.
Enzymes contain a globular protein part called apoenzyme and a non-protein part named cofactor or prosthetic group or metal-ion-activator. Changes in temperature and pH have great influence on the intra- and intermolecular bonds that hold the protein part in their secondary and tertiary structures.
Examples of cofactors are 1. Prosthetic group that are permanently bound to the enzyme. 2. Activator group which are cations (positively charged metal ions) & temporarily bind to the active site of the enzyme. 3.Coenzymes, usually vitamins or made from vitamins which are not permanently bound to the enzyme molecule, but combine with the enzyme-substrate complex temporarily. Enzymes require the presence cofactors before their catalytic activity can be exerted. This entire active complex is referred to as the holoenzyme.
Without enzymes, our guts would take weeks to digest our food, our muscles, nerves and bones would not work properly and so on…
Main Enzyme category groups:
Oxidoreductases:
All enzymes that catalyse oxido-reductions belong in this class. The substrate oxidized is regarded as a hydrogen or electron donor. The classification is based on 'donor:acceptor oxidoreductase'. The common name is 'dehydrogenase', wherever this is possible; as an alternative, 'acceptor reductase' can be used. 'Oxidase' is used only where O2 is an acceptor. Classification is difficult in some cases, because of the lack of specificity towards the acceptor.
Transferases:
Transferases are enzymes that transfer a group, for example, the methyl group or a glycosyl group, from one compound (generally regarded as donor) to another compound (generally regarded as acceptor). The classification is based on the scheme 'donor:acceptor grouptransferase'. The common names are normally formed as 'acceptor grouptransferase' or 'donor grouptransferase'. In many cases, the donor is a cofactor (coenzyme) that carries the group to be transferred. The aminotransferases constitute a special case.
Hydrolases:
These enzymes catalyse the hydrolysis of various bonds. Some of these enzymes pose problems because they have a very wide specificity, and it is not easy to decide if two preparations described by different authors are the same, or if they should be listed under different entries. While the systematic name always includes 'hydrolase', the common name is, in most cases, formed by the name of the substrate with the suffix -ase. It is understood that the name of the substrate with this suffix, and no other indicator, means a hydrolytic enzyme. It should be noted that peptidases have recommended names rather than common names.
Lyases:
Lyases are enzymes that cleave C-C, C-O, C-N and other bonds by means other than by hydrolysis or oxidation. They differ from other enzymes in that two (or more) substrates are involved in one reaction direction, but there is one compound fewer in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring. The systematic name is formed according to 'substrate group-lyase'. In common names, expressions like decarboxylase, aldolase, etc. are used. 'Dehydratase' is used for those enzymes that eliminate water. In cases where the reverse reaction is the more important, or the only one to be demonstrated, 'synthase' may be used in the name.
Ligases:
Ligases are enzymes that catalyse the joining of two molecules with concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate. 'Ligase' is often used for the common name, but, in a few cases, 'synthase' or 'carboxylase' is used. 'Synthetase' may be used in place of 'synthase' for enzymes in this class.
- 41701(11)
- Activating Transcription Factor(3)
- Adenylate Kinase(10)
- AHCY(3)
- Aldolase(9)
- Asparaginase(5)
- Aurora Kinase(18)
- Beta Lactamase(3)
- Calcium and Integrin Binding(2)
- Calcium/Calmodulin-Dependent Protein Kinase(4)
- Carbonic Anhydrase(49)
- Casein Kinase(36)
- Cathepsin(52)
- Chitinase(5)
- Creatin Kinases(9)
- Cyclin(7)
- Cyclin-Dependent Kinase(18)
- Cyclophilin(23)
- Deaminase(14)
- Decarboxylase(12)
- Dehydrogenase(96)
- Discoidin Domain Receptor Tyrosine Kinase(2)
- DNA Polymerase(4)
- EGF Receptor(3)
- Endonuclease(6)
- Enolase(10)
- Enterokinase(5)
- Epimerase(3)
- Esterase(15)
- FGF Receptors(12)
- FK506 Binding Protein(10)
- Fructosamine 3 Kinase(2)
- Galactosidase(5)
- Glucosidase(32)
- Gluteradoxin(7)
- Glycogen synthase kinase(2)
- Glycosylase(10)
- Glyoxalase(3)
- Granzyme(7)
- Guanylate Kinase(2)
- Heparanase(3)
- Histone Deacetylase(3)
- Hydratase(10)
- Hydrolase(33)
- Hydroxylase(6)
- Isomerase(26)
- Jun N-terminal Kinase(1)
- Jun Proto-Oncogene(2)
- Kallikrein(26)
- Ligase(4)
- Lipase(14)
- Lipocalin(6)
- Lyase(9)
- LYVE1(3)
- Mitogen-Activated Protein Kinase(16)
- MMP(71)
- Mutase(11)
- Natural Enzymes(4)
- Nuclease(18)
- Nucleotidase(4)
- Nudix Type Motif(11)
- Other Enzymes(63)
- Oxidase(23)
- Oxygenase(12)
- Paraoxonase(3)
- Peptidase(41)
- Peroxiredoxin(10)
- Phosphatase(150)
- Phosphorylase(9)
- PI3-kinase(5)
- Polymerase(13)
- PPARG(2)
- Protease(15)
- Proteasome(55)
- Protein Kinase Akt1/PKB alpha(4)
- Protein Kinase-A(7)
- Protein Kinase-C(3)
- Protein Kinases(86)
- Protein Tyrosine Phosphatase(10)
- Reductase(60)
- Secreted Phospholipase A2(10)
- Serine Threonine Kinase(4)
- Sulfatase(8)
- Synthase(23)
- Synthetase(33)
- TGFBR(3)
- TGM2(3)
- TIE1,TIE2
- TIMP(10)
- TPA(4)
- ransaminase
- Transferase(156)
- Tyrosine Kinase(9)
- Ubiquitin Conjugating Enzyme(39)
- Uromodulin(4)
- VEGF Receptors(14)
- Transaminase(19)
- Hexokinase(6)
- TIE1(6)
Enzymes 相关产品(1726)
- GC67947Triolein 13C3CAS: 82005-46-7
Triolein 13C3 是一种 13C 标记的 Triolein。Triolein 是一种对称三酰甘油,能够减少 MMP-1 的上调,具有很强的抗氧化、抗炎活性。
- GC67983NorathyriolCAS: 3542-72-1纯度: >99.00%
Norathyriol (Mangiferitin) 是芒果苷的天然代谢物。 Norathyriol 以非竞争性方式抑制 α-葡萄糖苷酶 (α-glucosidase ),IC50 为 3.12 μM。Norathyriol 还抑制 PPARα、PPARβ 和 PPARγ,IC50 分别为 92.8 µM、102.4 µM 和 153.5 µM。具有抗氧化、抗癌、抗菌、抗炎、抗菌活性。
- GC68008GÜ2602CAS: 1627094-88-5
GÜ2602 是一种有效的、可逆的组织蛋白酶 K (cathepsin K (CatK)) 抑制剂,对 成熟 CatK (mCatK) 的 Ki 值为 0.013 nM。GÜ2602 抑制组织蛋白酶 K 酶原的自催化激活。
- GC68147dAURK-4 hydrochloride
dAURK-4 hydrochloride 是 Alisertib 的一种衍生物,是一种有效的选择性 AURKA (Aurora A) 降解剂。dAURK-4 hydrochloride 具有抗癌作用。
- GC68437Vimentin-IN-1CAS: 2319587-80-7
Vimentin-IN-1 是 FiVe1 衍生物,是一种口服有效的选择性抗癌剂。FiVe1 能够结合 III 型中间丝蛋白 vimentin (VIM),诱导 Ser56 过度磷酸化,导致有丝分裂的选择性中断和转化表达 VIM 的间充质癌细胞的多核化。Vimentin-IN-1 比 FiVe1 表现出更好的口服利用度和药代动力学特征。
- GC6850320S Proteasome activator 1CAS: 2761578-18-9
20S Proteasome activator 1 是一种有效的 20S 蛋白酶激活剂,对胰蛋白酶样位点、胰凝乳蛋白酶样位点和半胱天冬酶位点的 IC50 分别为 0.3 μM、0.7 μM 和 1.8 μM。20S Proteasome activator 1 能在细胞系统中翻译,防止致病性 α-synuclein A53T 突变体积累。20S Proteasome activator 1 可用于神经退行性疾病的研究。
- GC68525(2α,3β,4α)-2,3,19-Trihydroxyurs-12-ene-23,28-dioic acidCAS: 132282-70-3
(2α,3β,4α)-2,3,19-Trihydroxyurs-12-ene-23,28-dioic acid 是一种可从 Rubus ellipticus var. obcordatus 中分离得到的皂苷。(2α,3β,4α)-2,3,19-Trihydroxyurs-12-ene-23,28-dioic acid 抑制 α-Glucosidase,其 IC50 为 1.68 mM。
- GC68620Ac-VLPE-FMKCAS: 2679825-27-3纯度: >99.00%
Ac-VLPE-FMK 是一种四肽基单氟甲基酮 (m-FMK),是一种 Cat-B 和 Cat-L 抑制剂。Ac-VLPE-FMK 可用于癌症侵袭性研究。
- GC68656AndecaliximabCAS: 1518996-49-0纯度: >95.00%
Andecaliximab 是一种靶向基质金属蛋白酶 9 (MMP9) 的重组 IgG4 单克隆抗体。Andecaliximab 在特发性肺纤维化小鼠模型中显示出抗纤维化疗效。Andecaliximab 可用于胃腺癌和特发性肺纤维化 (IPF) 的研究。
- GC68830Carbonic anhydrase inhibitor 2CAS: 2758231-43-3纯度: >98.00%
Carbonic anhydrase inhibitor 2 (compound 7c) 是一种碳酸酐酶 II (carbonic anhydrase II) 抑制剂,可降低青光眼兔的眼压。
- GC68836Cathepsin X-IN-1CAS: 2418577-51-0纯度: >98.00%
Cathepsin X-IN-1 (compound 25) 是一种有效的 组织蛋白酶 X 抑制剂,IC50 为 7.13 µM。Cathepsin X-IN-1 降低 PC-3 细胞迁移且具有低细胞毒性。
- GC68925cyclo(RLsKDK) TFA纯度: >99.00%
cyclo(RLsKDK) (TFA) (BK-1361 (TFA)) 是一种特异性的金属蛋白酶 ADAM8 抑制剂,IC50 值为 182 nM。cyclo(RLsKDK) (TFA) 在炎性疾病和癌症中有潜在应用。
- GC69068ENMD-2076 TartrateCAS: 1453868-32-0纯度: >99.00%
ENMD-2076 Tartrate 是多靶点激酶抑制剂,抑制 Aurora A,Flt3,KDR/VEGFR2,Flt4/VEGFR3,FGFR1,FGFR2,Src,PDGFRα 的IC50 值分别为1.86,14,58.2,15.9,92.7,70.8,20.2 and 56.4 nM。
- GC69155Gcase activator 2CAS: 2759897-35-1纯度: >99.00%
Gcase activator 2 (compound 14) 是一种吡咯 [2,3-b] 吡嗪,也是一种 β-葡萄糖脑苷酶 ( Gcase ) 激活剂(EC50=3.8 μM)。Gcase activator 2 诱导 Gcase 二聚化 (包括 k 型和 v 型)。Gcase activator 2 在人和小鼠中具有较低的代谢清除率。
- GC69209hCAII-IN-8CAS: 952306-80-8纯度: >99.00%
hCAII-IN-8 是一种酰胺,是一种高选择性碳酸酐酶 (CA) 抑制剂,对 hCA II 的 IC50 值为 0.18 μM。
- GC69480MMP-7-IN-1CAS: 2865097-05-6纯度: >99.00%
MMP-7-IN-1 是一种有效的、选择性 MMP-7 抑制剂 (IC50=10 nM),而对 MMP-1, -2, -3, -8, -9, -13 的 IC50>11 mM。MMP-7 是癌症和纤维化等疾病的潜在靶点。
- GC69551N-Ethylmaleimide-d5CAS: 360768-37-2纯度: >98.00%
N-Ethylmaleimide-d5 是 N-Ethylmaleimide 的氘代物。N-Ethylmaleimide (NEM),烷基化自由巯基的试剂, 是一种半胱氨酸蛋白酶抑制剂。N-Ethylmaleimide 特异性抑制线粒体中的磷酸盐转运。N-Ethylmaleimide 同样也是一种去泛素化酶 (deubiquitinating enzyme) 抑制剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC67938 | Guaiacin | 36531-08-5 | - | |
Guaiacin 是从 Machilus thunbergii SIEB. et ZUCC 的树皮中分离的芳基萘型木质素。Guaiacin 显着增加碱性磷酸酶活性和成骨细胞分化。 | ||||
| GC67947 | Triolein 13C3 | 82005-46-7 | - | |
Triolein 13C3 是一种 13C 标记的 Triolein。Triolein 是一种对称三酰甘油,能够减少 MMP-1 的上调,具有很强的抗氧化、抗炎活性。 | ||||
| GC67983 | Norathyriol | 3542-72-1 | >99.00% | |
Norathyriol (Mangiferitin) 是芒果苷的天然代谢物。 Norathyriol 以非竞争性方式抑制 α-葡萄糖苷酶 (α-glucosidase ),IC50 为 3.12 μM。Norathyriol 还抑制 PPARα、PPARβ 和 PPARγ,IC50 分别为 92.8 µM、102.4 µM 和 153.5 µM。具有抗氧化、抗癌、抗菌、抗炎、抗菌活性。 | ||||
| GC68008 | GÜ2602 | 1627094-88-5 | - | |
GÜ2602 是一种有效的、可逆的组织蛋白酶 K (cathepsin K (CatK)) 抑制剂,对 成熟 CatK (mCatK) 的 Ki 值为 0.013 nM。GÜ2602 抑制组织蛋白酶 K 酶原的自催化激活。 | ||||
| GC68147 | dAURK-4 hydrochloride | - | - | |
dAURK-4 hydrochloride 是 Alisertib 的一种衍生物,是一种有效的选择性 AURKA (Aurora A) 降解剂。dAURK-4 hydrochloride 具有抗癌作用。 | ||||
| GC68437 | Vimentin-IN-1 | 2319587-80-7 | - | |
Vimentin-IN-1 是 FiVe1 衍生物,是一种口服有效的选择性抗癌剂。FiVe1 能够结合 III 型中间丝蛋白 vimentin (VIM),诱导 Ser56 过度磷酸化,导致有丝分裂的选择性中断和转化表达 VIM 的间充质癌细胞的多核化。Vimentin-IN-1 比 FiVe1 表现出更好的口服利用度和药代动力学特征。 | ||||
| GC68503 | 20S Proteasome activator 1 | 2761578-18-9 | - | |
20S Proteasome activator 1 是一种有效的 20S 蛋白酶激活剂,对胰蛋白酶样位点、胰凝乳蛋白酶样位点和半胱天冬酶位点的 IC50 分别为 0.3 μM、0.7 μM 和 1.8 μM。20S Proteasome activator 1 能在细胞系统中翻译,防止致病性 α-synuclein A53T 突变体积累。20S Proteasome activator 1 可用于神经退行性疾病的研究。 | ||||
| GC68525 | (2α,3β,4α)-2,3,19-Trihydroxyurs-12-ene-23,28-dioic acid | 132282-70-3 | - | |
(2α,3β,4α)-2,3,19-Trihydroxyurs-12-ene-23,28-dioic acid 是一种可从 Rubus ellipticus var. obcordatus 中分离得到的皂苷。(2α,3β,4α)-2,3,19-Trihydroxyurs-12-ene-23,28-dioic acid 抑制 α-Glucosidase,其 IC50 为 1.68 mM。 | ||||
| GC68620 | Ac-VLPE-FMK | 2679825-27-3 | >99.00% | |
Ac-VLPE-FMK 是一种四肽基单氟甲基酮 (m-FMK),是一种 Cat-B 和 Cat-L 抑制剂。Ac-VLPE-FMK 可用于癌症侵袭性研究。 | ||||
| GC68656 | Andecaliximab | 1518996-49-0 | >95.00% | |
Andecaliximab 是一种靶向基质金属蛋白酶 9 (MMP9) 的重组 IgG4 单克隆抗体。Andecaliximab 在特发性肺纤维化小鼠模型中显示出抗纤维化疗效。Andecaliximab 可用于胃腺癌和特发性肺纤维化 (IPF) 的研究。 | ||||
| GC68830 | Carbonic anhydrase inhibitor 2 | 2758231-43-3 | >98.00% | |
Carbonic anhydrase inhibitor 2 (compound 7c) 是一种碳酸酐酶 II (carbonic anhydrase II) 抑制剂,可降低青光眼兔的眼压。 | ||||
| GC68836 | Cathepsin X-IN-1 | 2418577-51-0 | >98.00% | |
Cathepsin X-IN-1 (compound 25) 是一种有效的 组织蛋白酶 X 抑制剂,IC50 为 7.13 µM。Cathepsin X-IN-1 降低 PC-3 细胞迁移且具有低细胞毒性。 | ||||
| GC68925 | cyclo(RLsKDK) TFA | - | >99.00% | |
cyclo(RLsKDK) (TFA) (BK-1361 (TFA)) 是一种特异性的金属蛋白酶 ADAM8 抑制剂,IC50 值为 182 nM。cyclo(RLsKDK) (TFA) 在炎性疾病和癌症中有潜在应用。 | ||||
| GC69068 | ENMD-2076 Tartrate | 1453868-32-0 | >99.00% | |
ENMD-2076 Tartrate 是多靶点激酶抑制剂,抑制 Aurora A,Flt3,KDR/VEGFR2,Flt4/VEGFR3,FGFR1,FGFR2,Src,PDGFRα 的IC50 值分别为1.86,14,58.2,15.9,92.7,70.8,20.2 and 56.4 nM。 | ||||
| GC69090 | EWP 815 | 20231-01-0 | >98.00% | |
EWP 815 是一种二硫类似物,是 Ins(1,4)P2 磷酸酶和 Ins(1,4,5)P3 5-磷酸酶的有效抑制剂。EWP 815 也参与抑制体内多巴胺酶 β-羟化酶活性。 | ||||
| GC69155 | Gcase activator 2 | 2759897-35-1 | >99.00% | |
Gcase activator 2 (compound 14) 是一种吡咯 [2,3-b] 吡嗪,也是一种 β-葡萄糖脑苷酶 ( Gcase ) 激活剂(EC50=3.8 μM)。Gcase activator 2 诱导 Gcase 二聚化 (包括 k 型和 v 型)。Gcase activator 2 在人和小鼠中具有较低的代谢清除率。 | ||||
| GC69209 | hCAII-IN-8 | 952306-80-8 | >99.00% | |
hCAII-IN-8 是一种酰胺,是一种高选择性碳酸酐酶 (CA) 抑制剂,对 hCA II 的 IC50 值为 0.18 μM。 | ||||
| GC69231 | HKB99 | 2414908-90-8 | >97.00% | |
HKB99 是磷酸甘油酸突变酶 1 的变构抑制剂 (PGAM1)。HKB99 抑制侵袭性伪足的形成,提高 PAI-2 水平。HKB99 增加氧化应激,激活 JNK/c-Jun,抑制 AKT 和 ERK。HKB99 可用于非小细胞肺癌 (NSCLC) 的研究。 | ||||
| GC69315 | JMS-053 | 1954650-11-3 | - | |
JMS-053 是一种有效,选择性和可逆的 PTP4A 抑制剂,抑制 PTP4A1,PTP4A2,PTP4A3,CDC25B 和 DUSP3 的 IC50 值分别为 29.1 nM,48.0 nM,34.7 nM,92.6 nM 和 207.6 nM。JMS-053 可以抑制癌细胞迁移和球状体生长,减弱体内卵巢肿瘤的生长。 | ||||
| GC69323 | JUN-1111 | 874351-38-9 | >98.00% | |
JUN-1111 是一种不可逆的选择性 Cdc25 磷酸酶 抑制剂,对 Cdc25A、Cdc25B、Cdc25C、VHR、PTP1B的 IC50 值分别为 0.38、1.8、0.66、28、37 µM。 JUN-1111 诱导细胞周期停滞在 G1 和 G2/M 期。JUN-1111 降低 phosphoCdk1 的表达。 | ||||
| GC69479 | MMP2-IN-1 | 2764598-01-6 | - | |
MMP2-IN-1 是一种中度有效的 MMP2 抑制剂,IC50 为 6.8 µM。MMP2-IN-1 通过阻滞细胞周期和诱导细胞凋亡 (apoptosis),在某些癌细胞中表现出显著的抗增殖活性。 | ||||
| GC69480 | MMP-7-IN-1 | 2865097-05-6 | >99.00% | |
MMP-7-IN-1 是一种有效的、选择性 MMP-7 抑制剂 (IC50=10 nM),而对 MMP-1, -2, -3, -8, -9, -13 的 IC50>11 mM。MMP-7 是癌症和纤维化等疾病的潜在靶点。 | ||||
| GC69515 | MY33-3 | 2204280-41-9 | - | |
MY33-3 是一种有效和选择性的蛋白酪氨酸磷酸酶 RPTPβ/ζ 抑制剂,IC50 值为 ~0.1 μM。MY33-3 还抑制 PTP-1B (IC50 ~0.7 μM)。MY33-3 可以减少乙醇消耗并缓解 Sevoflurane 引起的神经炎症和认知功能障碍。 | ||||
| GC69551 | N-Ethylmaleimide-d5 | 360768-37-2 | >98.00% | |
N-Ethylmaleimide-d5 是 N-Ethylmaleimide 的氘代物。N-Ethylmaleimide (NEM),烷基化自由巯基的试剂, 是一种半胱氨酸蛋白酶抑制剂。N-Ethylmaleimide 特异性抑制线粒体中的磷酸盐转运。N-Ethylmaleimide 同样也是一种去泛素化酶 (deubiquitinating enzyme) 抑制剂。 | ||||
